Literature DB >> 9607639

Survival analysis of 306 European Spanish patients with systemic lupus erythematosus.

F J Blanco1, J J Gómez-Reino, J de la Mata, A Corrales, V Rodríguez-Valverde, J C Rosas, A Gómez de la Camara, E Pascual.   

Abstract

OBJECTIVE: To describe survival of lupus in South European Spanish patients. PATIENTS AND METHODS: Observational study of all SLE Spanish patients seen at three University Hospitals between 1975 and 1993. The charts of all patients were retrospectively reviewed. Sixty-four clinic and laboratory variables were extracted from charts. Univariate analysis, multivariate Cox proportional hazard regression analysis, actuarial life tables and multiple logistic regression analysis were used to calculate survival probability and identify variables associated with survival.
RESULTS: Three hundred and six (275 female and 31 male) patients were identified. Their mean age at diagnosis was 31.9 years (range 4 to 85). The mean duration of followup was 79 (1-126) months. Thirty-one patients died. The most common cause of death was infection (29%). Five, 10 and 15 years' survival rate was 90%+/-0.0158, 85%+/-0.0262 and 80%+/-0.0413, respectively. Log-rank analysis showed that male sex, proteinuria and nephropathy at diagnosis were associated with poor survival. By univariate and multivariate analysis male gender, nephropathy and CNS involvement were associated with worse survival.
CONCLUSION: In SLE patients from Spain, rate of survival is similar to other Caucasian patients, and better than other ethnic groups of Spanish ancestry. Other factors rather than genetic factors could explain our findings.

Entities:  

Mesh:

Year:  1998        PMID: 9607639     DOI: 10.1191/096120398678919930

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  11 in total

1.  Optimising testing for phospholipid antibodies.

Authors:  M Helbert; S Bodger; J Cavenagh; D D'Cruz; J M Thomas; P MacCallum
Journal:  J Clin Pathol       Date:  2001-09       Impact factor: 3.411

Review 2.  [Changes in mortality and morbidity in systemic lupus erythematosus].

Authors:  G Chehab; R Fischer-Betz; M Schneider
Journal:  Z Rheumatol       Date:  2011-08       Impact factor: 1.372

3.  Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus.

Authors:  K Manger; B Manger; R Repp; M Geisselbrecht; A Geiger; A Pfahlberg; T Harrer; J R Kalden
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

4.  Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.

Authors:  Mikiko Tokunaga; Kazuyoshi Saito; Daisuke Kawabata; Yoshitaka Imura; Takao Fujii; Shingo Nakayamada; Shizuyo Tsujimura; Masao Nawata; Shigeru Iwata; Taeko Azuma; Tsuneyo Mimori; Yoshiya Tanaka
Journal:  Ann Rheum Dis       Date:  2006-11-15       Impact factor: 19.103

5.  Development and Verify of Survival Analysis Models for Chinese Patients With Systemic Lupus Erythematosus.

Authors:  Linyu Geng; Wenqiang Qu; Jun Liang; Wei Kong; Xue Xu; Wenyou Pan; Lin Liu; Min Wu; Fuwan Ding; Huaixia Hu; Xiang Ding; Hua Wei; Yaohong Zou; Xian Qian; Meimei Wang; Jian Wu; Juan Tao; Jun Tan; Zhanyun Da; Miaojia Zhang; Jing Li; Huayong Zhang; Xuebing Feng; Jiaqi Chen; Lingyun Sun
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

Review 6.  Review: Male systemic lupus erythematosus: a review of sex disparities in this disease.

Authors:  L-J Lu; D J Wallace; M L Ishimori; R H Scofield; M H Weisman
Journal:  Lupus       Date:  2009-11-27       Impact factor: 2.911

7.  Survival analysis of late-onset systemic lupus erythematosus: a cohort study in China.

Authors:  Hui Lin; James Cheng-chung Wei; Chun-yu Tan; Yuan-yuan Liu; Yan-hong Li; Feng-xia Li; Dai-hua Deng; Bing Yan; Yi Liu; Yi Zhao
Journal:  Clin Rheumatol       Date:  2012-09-15       Impact factor: 2.980

Review 8.  Understanding the epidemiology and progression of systemic lupus erythematosus.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Lacie Scofield; Leslie Reinlib; Glinda S Cooper
Journal:  Semin Arthritis Rheum       Date:  2009-01-10       Impact factor: 5.532

9.  Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients.

Authors:  S Buján; J Ordi-Ros; J Paredes; M Mauri; L Matas; J Cortés; M Vilardell
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

Review 10.  Pneumococcal vaccination in autoimmune rheumatic diseases.

Authors:  Éva Rákóczi; Zoltan Szekanecz
Journal:  RMD Open       Date:  2017-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.